j&j

J&J MedTech Navigates Headwinds, Eyes Growth Surge in Second Half of 2024
J&J MedTech Navigates Headwinds, Eyes Growth Surge in Second Half of 2024
July 17, 2024  |  Healthcare

Johnson & Johnson’s (J&J) MedTech arm displayed resilience in its second quarter, navigating inflationary headwinds while prioritizing innovation. The unit, a key driver for J&J,...

READ MORE >
Johnson & Johnson Amplifies MedTech Profile in Q1 Earnings
Johnson & Johnson Amplifies MedTech Profile in Q1 Earnings
April 16, 2024  |  Earnings

Johnson & Johnson (J&J) has emphasized the pivotal role of medical technology (MedTech) in advancing healthcare. During a Tuesday (April 16) call with analysts to discuss...

READ MORE >
J&J’s Medical Device Sales Feel the Side Effects of Weight-Loss Drugs 
J&J’s Medical Device Sales Feel the Side Effects of Weight-Loss Drugs 
October 17, 2023  |  Healthcare

Riding high, Johnson & Johnson reported pharmaceutical sales worth $13.89 billion on Tuesday (Oct 17), a year-over-year growth exceeding 5%.  The pharmaceuticals driving its growth...

READ MORE >
J&J Sees Q3 Boost as Consumers Resume Elective Surgeries
J&J Sees Q3 Boost as Consumers Resume Elective Surgeries
October 18, 2022  |  Earnings

Healthcare giant Johnson & Johnson (J&J) said Tuesday (Oct. 18) that strong pharmaceutical sales and a recovery in medical procedures helped offset economic headwinds and...

READ MORE >